Cantitate/Preț
Produs

Formulation, Characterization, and Stability of Protein Drugs: Case Histories: Pharmaceutical Biotechnology, cartea 9

Editat de Rodney Pearlman, Y. John Wang
en Limba Engleză Hardback – 31 oct 1996
Leading scientists offer detailed profiles of ten protein drugs currently in development. The case histories of these important new compounds are described from the perspective of their formulation, characterization, and stability. This ready reference also features recent data and an abundance of previously unpublished information. The in-depth coverage includes a highly useful compendium of degradation sites occurring in over 70 proteins. An invaluable aid in the rapid identification of potential `hot spots' in proteins, this accessible compilation allows for inspection of the protein's primary structure and preparation of a hydroflex plot.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 137702 lei  6-8 săpt.
  Springer Us – 6 mai 2013 137702 lei  6-8 săpt.
Hardback (1) 138466 lei  6-8 săpt.
  Springer Us – 31 oct 1996 138466 lei  6-8 săpt.

Din seria Pharmaceutical Biotechnology

Preț: 138466 lei

Preț vechi: 145754 lei
-5% Nou

Puncte Express: 2077

Preț estimativ în valută:
26501 27957$ 22084£

Carte tipărită la comandă

Livrare economică 03-17 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780306453328
ISBN-10: 0306453320
Pagini: 432
Ilustrații: XXVIII, 432 p.
Dimensiuni: 155 x 235 x 30 mm
Greutate: 0.81 kg
Ediția:2002
Editura: Springer Us
Colecția Springer
Seria Pharmaceutical Biotechnology

Locul publicării:New York, NY, United States

Public țintă

Research

Cuprins

A Compendium and Hydropathy/ Flexibility Analysis of Common Reactive Sites in Proteins: Reactivity at Asn, Asp, Gin, and Met Motifs in Neutral pH Solution.- Characterization, Stability, and Formulations of Basic Fibroblast Growth Factor.- The Characterization, Stabilization, and Formulation of Acidic Fibroblast Growth Factor.- Stability, Characterization, Formulation, and Delivery System Development for Transforming Growth Factor-Beta1.- Stability and Characterization of Recombinant Human Relaxin.- Interferon-?-1b (Betaseron®): A Model for Hydrophobic Therapeutic Proteins.- Characterization, Formulation, and Stability of Neupogen® (Filgrastim), a Recombinant Human Granulocyte-Colony Stimulating Factor.- Development and Shelf-Life Determination of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (LEUKINE®, GM-CSF).- Formulation Development of an Antifibrin Monoclonal Antibody Radiopharmaceutical.- Biophysical Characterization and Formulation of TP40: A Chimeric Protein that Requires a pH-Dependent Conformational Change for Its Biological Activity.- Stability Characterization and Formulation Development of Recombinant Human Deoxyribonuclease I [Pulmozyme®, (Dornase Alpha)].